top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cellular Senescence in Health, Disease and Aging: Blessing or Curse?
Cellular Senescence in Health, Disease and Aging: Blessing or Curse?
Autore Riessland Markus
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (112 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato γH2AX
Alzheimer's disease
DNA damage
mild cognitive impairment
senescence
secreted protein acidic and rich in cysteine
regeneration
homeostasis
cellular senescence
biology of aging
neurodegeneration
brain
geroscience
senolytics
tauopathy
cancer
stress response
post-mitotic
neuronal senescence
amyotrophic lateral sclerosis
senescence-associated secretory phenotype (SASP)
cell-cycle
melanoma
pancreatic adenocarcinoma
tumor infiltration
chemotherapy resistance
prostate
inflammation
AIM2 inflammasome
POP3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cellular Senescence in Health, Disease and Aging
Record Nr. UNINA-9910557382703321
Riessland Markus  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
Autore Cavallaro Ugo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (208 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato Cadherin 11
WNT signaling
β-catenin
cancer stem cells
TNBC
early breast cancer
bevacizumab
neoadjuvant chemotherapy
ALDH1
solid cancer
chemo-resistance
HDAC inhibitors
head and neck squamous cell carcinoma
SRC
dasatinib
saracatinib
EC-8042
Ovarian cancer
Wnt signaling
tumor progression
therapy resistance
exosomes
oral cancer risk
oral epithelial dysplasia
SOX2
immunohistochemistry
oral squamous cell carcinoma
genome-wide
transcriptome
lung cancer
ATAC-seq
RNA-seq
CSCs
NSCLC
B4GALT1
LUAD
breast cancer
lipid
metabolism
therapeutic resistance
bowel cancer
organoid
tumoroid
colorectal
colon
stem cell
chemotherapy resistance
ovarian cancer
cancer stem cell
genetic heterogeneity
SNP array
L1CAM
chemoresistance
epithelial-mesenchymal transition
cancer therapy
cell adhesion molecule
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti New Aspects of Cancer Stem Cell Biology
Record Nr. UNINA-9910557112003321
Cavallaro Ugo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Autore Moriggl Richard
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (578 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato multiple myeloma
STAT3
S3I-1757
nanoparticle
CD38
siRNA/RNAi
polyethylenimine
PEI
lipopolyplex
siRNA delivery
glioma
glioblastoma
STAT5
AKT
ERK1/2
prolactin
androgens
prostate cancer
knockout
escape mechanisms
stem/progenitor cells
cell hierarchy
cancer
CD4+ T cells
CD8+ T cells
myeloid cells
immune check point
hepatitis C virus (HCV)
cirrhosis
hepatocellular carcinoma (HCC)
endoplasmic reticulum (ER) stress
oxidative stress (OS)
unfolded protein response (UPR)
microRNA-122 (miR-122)
nuclear factor erythroid 2-related factor 2 (NRF2)
signal transducer and activator of transcription 3 (STAT3)
hepatocyte nuclear factor 4 alpha (HNF4A)
solid cancers
cell cycle
apoptosis
inflammation
mitochondria
stemness
tumor suppression
melanoma
autoimmune disease
immunotherapy
tumor-immune cell interactions
breast cancer
PD-L1
M2 macrophages
NK cells
STAT3 inhibitor XIII
hedging
transaction costs
dynamic programming
risk management
post-decision state variable
cancer progression
cancer-stem cell
cytokine
therapy resistance
metastasis
immunosuppression
tumor microenvironment
proliferation
tyrosine kinase 2
JAK family of protein tyrosine kinases
signal transducer and activator of transcription
cytokine receptor signaling
gain-of-function mutation
tumorigenesis
ADAM17
interleukin-6
trans-signaling
epidermal growth factor receptor (EGF-R)
shedding
metalloprotease
tumor necrosis factor alpha (TNFα)
inflammation associated cancer
colon cancer
lung cancer
SH2 domain
mutations
autosomal-dominant hyper IgE syndrome
inflammatory hepatocellular adenomas
T-cell large granular lymphocytic leukemia
T-cell prolymphocytic leukemia
growth hormone insensitivity syndrome
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
targeting
tumor-associated macrophages
adoptive T cell therapy
immune suppression
STAT transcription factors
JAK
STAT
T-PLL
T-cell leukemia
meta-analysis
STAT5B signaling
small-molecule inhibitors
cancer models
companion animals
comparative oncology
pharmacological inhibitor
STAT5 signaling
chemotherapy resistance
myeloid leukemia
heat shock proteins
chaperones
stabilization
targeted therapy
ovarian cancer
hematopoietic cancers
therapeutic targeting
pharmacological inhibitors
mTOR
Bone Marrow Failure Syndromes
lymphocytes
lymphoma
T-cells
RHOA
NGS
MPN
JAK2 V617F
neoplastic stem cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Moriggl Richard  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui